These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
5. [Problems about the management of active pulmonary tuberculosis patients undergoing haemodialysis--our experiences and nation-wide questionnaire survey]. Tomioka H; Tada K; Ohyama A; Fujiyama R; Ohnishi H; Sakurai T; Sakamoto H; Nishiguchi H; Yamamoto T; Sakashita T; Shirai C; Iwasaki H Kekkaku; 2003 Apr; 78(4):353-8. PubMed ID: 12739395 [TBL] [Abstract][Full Text] [Related]
6. Mycobacterial infections in renal transplant recipients. Seven cases and a review of the literature. Lloveras J; Peterson PK; Simmons RL; Najarian JS Arch Intern Med; 1982 May; 142(5):888-92. PubMed ID: 7044331 [TBL] [Abstract][Full Text] [Related]
7. Nontuberculous mycobacterial pulmonary infection in renal transplant recipients. Ho TA; Rommelaere M; Coche E; Yombi JC; Kanaan N Transpl Infect Dis; 2010 Apr; 12(2):138-42. PubMed ID: 19929882 [TBL] [Abstract][Full Text] [Related]
8. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months. Nolan CM; Goldberg SV Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140 [TBL] [Abstract][Full Text] [Related]
9. Tuberculosis in southern Chinese renal-transplant recipients. Chen SY; Wang CX; Chen LZ; Fei JG; Deng SX; Qiu J; Li J; Chen GO; Fu HM; Xie CM Clin Transplant; 2008; 22(6):780-4. PubMed ID: 19040560 [TBL] [Abstract][Full Text] [Related]
10. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [TBL] [Abstract][Full Text] [Related]
12. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment]. Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263 [TBL] [Abstract][Full Text] [Related]
13. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. Park SK; Kim CT; Song SD Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607 [TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations of tuberculosis in renal transplant patients. Park SB; Joo I; Park YI; Suk J; Cho WH; Park CH; Kim HC Transplant Proc; 1996 Jun; 28(3):1520-2. PubMed ID: 8658768 [No Abstract] [Full Text] [Related]
15. Pulmonary tuberculosis in renal transplant patients. Walker JF; O'Neill S; Hanson JS Ir Med J; 1981 Apr; 74(4):123-4. PubMed ID: 7014528 [No Abstract] [Full Text] [Related]